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Abstract
Background: South Africa endorses the global policy shift from primarily client-initiated voluntary counselling and
testing (VCT) to routine/provider-initiated testing and counselling (PITC). The reason for this policy shift has been to
facilitate uptake of HIV testing amongst at-risk populations in high-prevalence settings. Despite ostensible
implementation of routine/PITC, uptake amongst tuberculosis (TB) patients in this country remains a challenge.
This study presents the reasons that non-tested TB patients offered for their refusal of HIV testing and reflects on
all TB patients’ suggestions as to how this situation may be alleviated.
Methods: In February-March 2008, a cross-sectional survey was conducted amongst 600 TB patients across 61
primary health care facilities in four sub-districts in the Free State. Patient selection was done proportionally to the
numbers registered at each facility in 2007. Data were subjected to bivariate tests and content analysis of open-
ended questions.
Results: Almost one-third (32.5%) of the respondents reported that they had not undertaken HIV testing, with the
most often offered explanation being that they were ‘undecided’ (37.0%). Other self-reported reasons for non-
uptake included: fear (e.g. of testing HIV-positive, 19.0%); perception of being at low risk of HIV infection (13.4%);
desire first to deal with TB ‘on its own’ (12.5%); and because HIV testing had not been offered to them (12.0%).
Many patients expressed the need for support and motivation not only from health care workers (33.3%), but also
from their significant others (56.6%). Patients further expressed a need for (increased) dissemination of TB-HIV
information by health care workers (46.1%).
Conclusions: Patients did not undergo HIV testing for various patient-/individual-related reasons. Non-uptake of
HIV testing was also due to health system limitations such as the non-offer of HIV testing. Other measures may be
necessary to supplement routine/provider-initiation of HIV testing. From the TB patient’s perspective, there is a
need for (improved) dissemination of information on the TB-HIV link. Patients also require (repeated) motivation
and support to undergo HIV testing, the onus for which rests not only on the public health authority and health
care workers, but also on other people in the patients’ social support networks.
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Effective co-management of tuberculosis (TB) and
human immunodeficiency virus/acquired immunodefi-
ciency syndrome (HIV/AIDS) necessitates that TB
patients undergo HIV testing as early as possible after
TB diagnosis [1-3]. In South Africa, provider-initiation
of HIV testing for TB patients came into effect in 2007
with the adoption of the provider-initiated testing and
counselling (PITC) strategy in the Tuberculosis Strategic
Plan, 2007-2011 [4]. Findings of a study amongst provi-
ders in the Free State Province indicate that almost all
nurses (according to their own reports) recommend
HIV testing to TB patients, not only at inception of TB
treatment (88%), but at every contact (61%) with the
patient until acceptance of the test [5]. Despite such
commendable efforts, reports indicate that less than half
of the registered TB patients accepted HIV testing in
2007 (43.1%) and 2008 (45.9%) [6]. Indeed, at 39%,
South Africa achieved a much lower HIV-testing rate
amongst TB patients in 2007 than some other sub-
Saharan African countries (e.g. Kenya - 79%) also heav-
ily burdened with TB-HIV/AIDS [7].
In April 2010, following limited success of existing
HIV-testing policies, the South African government
initiated a mass HIV counselling and testing (HCT)
campaign aimed at identifying and treating as many eli-
gible persons as possible - TB patients included - before
June 2011 [8]. This step confirmed the concerns of
government and other interest groups that, despite
ostensible implementation of routine/provider-initiated
HIV testing, too many TB patients are currently not
undergoing HIV testing [1,9]. Research is thus needed
to identify obstacles to uptake, and to find ways to
improve the rate of HIV testing by TB patients in South
Africa. The reported research provides insight from a
patient perspective into why routine/provider-initiated
HIV testing has been less successful than might have
been expected in the case of TB patients. This study fol-
lows previous reports on predictors of uptake of HIV
testing amongst the same patient population [10,11].
It is important to establish patients’ views so as to gain
an understanding of non-utilisation of health services [12],
which also includes the non-uptake of HIV testing. Evi-
dence from studies conducted among TB populations else-
where indicates that non-uptake of HIV testing may be
attributed to: (1) patient-/individual-level factors, includ-
ing fear of HIV-related stigma, negative experiences dur-
ing prior HIV counselling, perceived lack of privacy at
HIV-testing facilities, and prior HIV testing [13-15]; (2)
relational factors, such as having to seek sexual partners’
consent before undergoing HIV testing [14]; and (3) health
systems factors, including lack of routine offering of HIV-
testing services to TB patients, shortages of HIV testing
kits, limited availability of HIV counsellors, poor inter-TB-
HIV clinic referral systems, and inadequate counselling
skills among providers [16].
However, no research has as yet been conducted to
establish patients’ reasons for non-uptake of HIV testing in
the Free State. Despite a decrease from 32.9% in 2008 to
30.9% in 2009, the province has recorded high rates of HIV
prevalence amongst antenatal women since 2007 (range:
30.1% to 32.9%) [17]. Moreover, at 818 cases per 100 000
population in 2007, the province had the fourth highest
incidence of TB in the country [18], with six in every ten
(60.3%) TB patients testing HIV-positive [6]. Our study
sought to identify non-tested TB patients and to explore
their reasons for not undergoing HIV testing. We also
report both tested and non-tested patients’ suggestions
regarding what can be done to encourage a greater number
of TB patients to undergo HIV testing. The survey formed
part of a larger ‘fact-finding’ research project to inform the
development of an intervention to improve uptake of HIV
testing by TB patients in the Free State [9].
Methods
Setting
Between February and March 2008, we conducted a
cross-sectional survey among TB patients in two ran-
domly selected districts, namely Thabo Mofutsanyana
and Lejweleputswa. Logistical limitations permitted the
purposive selection of only two sub-districts from each
district. These were Maluti-a-Phofung and Nketoana
from Thabo Mofutsanyana District, and Matjhabeng and
Masilonyana from Lejweleputswa District. Primary
health care (PHC) facilities in these sub-districts were
considered for inclusion in the study if they had pro-
vided (1) simultaneous TB and HIV services and (2) TB
services to at least ten patients during 2007. Sixty-one
out of a total of 97 PHC facilities met these criteria and
were thus included in the study.
Participants
The target population included all registered TB patients
aged 18 years or older attending PHC facilities in these
specific localities. A sample of 600 patients was consid-
ered for the study. The sample size was conservatively
estimated from an average of 2 238 patients registered
across the 61 PHC facilities during 2007. This was due
to a lack of previous studies on uptake of HIV counsel-
ling and testing amongst TB patients in the Free State
Province to guide statistical sample size calculations.
Based on the average number of TB patients registered
at each facility during 2007, the proportional-to-size
technique was used to determine the number of patients
to be recruited at each PHC facility. Patients were con-
veniently recruited just as they left TB consultation
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representativeness of our findings, comparison revealed
that the patient sample did not significantly differ from
the larger population of TB patients in the four sub-dis-
tricts under scrutiny in terms of key biographical vari-
ables, including sex and age [10].
Instrument and data collection
A structured interview schedule was developed for data
gathering. The schedule, comprising both closed- and
open-ended questions, was pre-tested for practicality
with ten TB patients at a PHC facility outside the study
areas. Information was gathered on biographical details
(sex, age and education); clinical aspects (patient treat-
ment category i.e. whether a patient was undergoing
initial [new] or subsequent [re-treatment] TB treatment,
treatment duration and HIV testing); HIV risk-reduction
practice (whether a condom was used during most
recent sex); HIV risk perception (worry about acquiring
HIV, already being infected with HIV or infecting others
if already infected with HIV); and service delivery
(whether the patient received information on the link
between TB and HIV at the PHC facility and whether
HIV testing was recommended to them).
The open-ended questions assessed: (1) patients’ expla-
nations for non-uptake of HIV testing, i.e. ‘Please explain
why you have never taken a test for HIV’;a n d( 2 )t h e i r
suggestions as to what could be done to improve their
uptake of such, i.e. ‘W h a tc a nb ed o n eb yh e a l t hc a r e
workers (for example doctors, nurses and community
health workers) in order to encourage more TB patients to
test for HIV?’; and ‘What can be done by other people (for
example family, friends and community) in order to
encourage more TB patients to test for HIV?’.
Data analysis
All closed-ended questions were classified as binary vari-
ables: sex (male/female); age (18-30 years/31 years or
older); patient category (new/re-treatment); treatment
duration (60 or less days [intensive treatment phase]/61
or more days [follow-up or continued treatment phase]);
whether a condom was used during most recent sex (yes/
no); worry about acquiring HIV (worried/not worried);
worry about already being infected with HIV (worried/
not worried); worry about infecting others if already
infected with HIV (worried/not worried); whether
patients received information on the link between TB
and HIV from the PHC facility (yes/no); and whether
HIV testing was recommended at the PHC facility (yes/
no). Differences between tested and non-tested patients
were examined using chi-square tests.
Content analysis [19,20] was employed in examining
responses to the open-ended questions. This approach
has been used in research regarding uptake of HIV
testing amongst injection drug users [21]. In respect of
each open-ended question, four coders used keywords
to group similar responses into subcategories for a sam-
ple of 25 respondents. After careful consideration and
comparison, similar subcategories were combined to
form a generic category. The resulting categories were
further scrutinised for similarities before compiling a
final shortlist of mutually-exclusive categories. One
coder then checked all the questionnaires for the fre-
quency of each of the established categories. Categories
with very low frequencies were combined to form the
category ‘other’. Next, the categories were grouped
under the three main themes that emerged from pre-
vious studies conducted on uptake of HIV testing
amongst TB patients elsewhere [13-15]. These themes
related to factors at the: (1) patient/individual level,( 2 )
relational level, and (3) health systems/services level.
Fieldworker training, ethical clearance and study approval
Ten fieldworkers, four male and six female, were trained
in a three-day course entailing lectures on the interview
process, i.e. introduction of the interview, mode of ask-
ing questions, accurate recording of responses, and the
use of probes to seek clarity. To improve consistency in
the asking of questions and reporting of answers by all
interviewers, the fieldworkers were trained to use the
exact wording used in the questionnaire and, in respect
of open-ended questions, to record responses verbatim.
The fieldworkers further participated in role plays to
facilitate their understanding of the questionnaire. Gen-
der issues between interviewers and interviewees were
r e d u c e db ya s s i g n i n g ,w h e r ep o s s i b l e ,am a l ea n da
female interviewer per PHC facility. In most cases, the
patients could thus choose whether they wanted to be
interviewed by a male or a female interviewer [19].
Patients’ participation in the study was voluntary and
based on informed consent and guarantee of confidenti-
ality. The fieldworkers explained the study to the
patients before requesting their written consent to parti-
cipate. Patients were assured that their names would
only be recorded for purposes of correlating question-
naires with their clinical data and would not appear in
any further analysis or reporting of the information.
The Committee for Research Ethics of the Faculty of
the Humanities, University of the Free State, approved
the study protocol. Permission to conduct the research
was granted by the Free State Department of Health at
the provincial, district and facility levels.
Results
Sample description
All of the 600 patients who were approached agreed to
participate in the study. Patients’ characteristics stratified
by HIV-test uptake are presented in Table 1. Almost
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gone HIV testing. Table 1 shows statistically significant
(p < 0.05) differences between HIV-tested and non-tested
respondents in respect of sex, patient treatment category,
whether a condom was used at most recent sex, whether
TB-HIV information was received from PHC facilities,
whether the patients were worried about already being
infected with HIV, and whether HIV testing had been
recommended to them at the PHC facilities.
Of the patients reporting non-uptake of HIV testing,
the majority of respondents were male (59.0%), older
than 30 years (52.8%), receiving TB treatment for the
first time (70.3%), and had been undergoing treatment
for more than two months (58.3%). More than half of
non-tested patients had not received information on the
link between TB and HIV from their PHC facilities
(56.9%), had not used a condom during their most
recent sexual activity (59.1%), expressed worry about the
possibility that they were already HIV-positive (56.8%),
and had not been recommended to undergo HIV testing
at the PHC facility (51.8%).
Non-tested patients’ explanations for non-uptake of HIV
testing
Figure 1 reflects non-tested patients’ explanations for
non-uptake of HIV testing.
Patient-/individual-level factors
Patient-/individual-level reasons comprised the leading
self-reported explanations for patients’ non-uptake of HIV
testing. Reasons were categorised as ‘undecided’ (37.0%) if
patients indicated that they were ‘still thinking about it’ or
‘were not [yet] ready’. All explanations eliciting some form
of expressed fear or apprehension were grouped under the
category ‘fear’ (19.0%). These fear-related reasons included
fear of HIV testing as such, fear of stigmatisation attached
to HIV, and/or fear of the consequences of testing HIV-
positive. A further category included patients who report-
edly were still grappling with being ill with TB and did not
wish to subject themselves to the potential burden of also
having to deal with HIV (12.5%), e.g. ‘I’m still on TB treat-
ment’ or ‘I’m still very sick’.
Relational factors
Patients also advanced reasons for non-uptake of HIV
testing that reflected the importance of relational factors.
Some patients used their sexual partners’ HIV-test results
as proxy for knowing their own HIV status, e.g. ‘Ik n o wI
am negative because my girlfriend tested and was nega-
tive’. Others stated that they did not need to test because
they were cautious or because they trusted their sexual
partners, e.g. ‘I am always careful’, ’Id on o td o[have sex
with] HIV girls’,a n d’It r u s tm y[partner]’.S i n c et h e s e
patients did not perceive themselves as being at risk
regarding HIV infection, their responses were grouped
under the category ‘no/low risk perception’ (13.4%).
Health systems-/service-related factors
The most frequent health service-related barrier identi-
fied was that some patients had reportedly not (yet)
been advised to undergo HIV testing (12.0%), e.g. ‘The
Table 1 Sample description (N = 600)
Tested for
HIV
(n = 405)
Not tested for
HIV (n = 195)
P-
value
Characteristics n (%) n (%) n (%)
Sex (n = 600)
Male 175 (43.2) 115 (59.0) 0.00
Female 230 (56.8) 80 (41.0)
Age in years
‡(n = 592)
18-30 218 (54.9) 92 (47.2) 0.07
31 and older 179 (45.1) 103 (52.8)
Education level (n = 600)
Primary and lower 145 (35.8) 76 (39.0) 0.45
Secondary and higher 260 (64.2) 119 (61.0)
Patient treatment category
(n = 594)
New 227 (56.5) 135 (70.3) 0.00
Re-treatment 175 (43.5) 57 (29.7)
Current TB treatment duration
in days (n = 590)
≤ 60 160 (40.2) 80 (41.7) 0.73
≥ 61 238 (59.8) 112 (58.3)
Received TB-HIV information
from PHC facility (n = 600)
No 103 (25.4) 111 (56.9)
Yes 302 (74.6) 84 (43.1) 0.00
Used condom during most
recent sex?* (n = 533)
No 173 (48.5) 104 (59.1) 0.02
Yes 184 (51.5) 72 (40.9)
Worry will get HIV? (n = 596)
Not worried at all 185 (45.8) 73 (38.0)
Worried 219 (54.2) 119 (62.0) 0.07
Worry already have HIV?
(n = 596)
Not worried at all 217 (53.7) 83 (43.2) 0.01
Worried 187 (46.3) 109 (56.8)
Worry will infect others if
already have HIV? (n = 596)
Not worried at all 189 (46.8) 95 (49.5)
Worried 215 (53.2) 97 (50.5) 0.54
Recommended for HIV
testing? (n = 600)
No 106 (26.2) 101 (51.8) 0.00
Yes 299 (73.8) 94 (48.2)
‡Mean age = 38.4 years, range = 18-73. *Excludes patients who had never
been sexually active or who had not been sexual active in the two months
prior to data collection.
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cited service-related explanations (6.0%) like: ‘The lay
counsellor is always late’, and ‘The clinic is always full’.
Suggestions towards increasing uptake of HIV counselling
and testing by TB patients
Both tested and non-tested patients perceived relational
and health systems factors as potential facilitators of
HIV-test uptake.
Relational factors
Figure 2 summarises the TB patients’ suggestions as to
what other people (e.g. family members, friends and
community) can do to make HIV testing more accepta-
ble to them. Most patients’ suggestions pointed to a per-
ceived need for motivation or support from others
(56.6%), e.g. ‘They should stress the importance of HIV
testing’, ‘...encourage very ill patients to consider HIV
testing’,a n d‘...create support groups’. The second most
frequent category of suggestions implored other people
to be more involved in creating awareness around TB
and HIV (14.3%), e.g. ‘They should read pamphlets to
patients’ and ‘...involve influential people in TB-HIV edu-
cation’. Some suggestions entreated other people to
refrain from stigmatising/discriminating against TB
patients (8.6%), e.g. ‘They should not judge patients’ and
‘...should not gossip about patients’. Suggestions cate-
gorised as ‘other’ included statements such as ‘They
should help patients without transport to [reach] clinics’
and ‘...accompany patients to clinics’.
Health systems-/service-related factors
Figure 3 illustrates the TB patients’ perceptions of how
health care workers (doctors, nurses and community
37.0
19.0
13.4 12.5 12.0
6.0
Indecisiveness Fear No/low risk 
perception
Still dealing 
with TB
HIV test not 
advised
Other
%
Figure 1 Patients’ reasons for non-uptake of HIV testing (n = 216 citations).
56.6
14.3
8.6 6.6
13.9
Motivation/support TB-HIV awareness No 
stigma/discrimination
Other Do not know
%
Figure 2 Patients’ suggestions on what other people can do to make HIV testing acceptable to TB patients (n = 698 citations).
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counselling and testing. Overall, the most frequent sug-
gestion was that health care workers should provide
patients with (more) information, education and com-
munication (IEC) about (the link between) TB and HIV
(46.1%), e.g. ‘They should give health talks’, ’...inform us
about the TB-HIV relationship’ and ’...show us pictures
of people who are sick [with AIDS]’.
As was the case with their suggestions regarding the
role of family, friends and communities in facilitating
uptake of HIV testing, patients also requested service
providers to motivate and to be more supportive of TB
patients (33.3%), e.g. ‘They should emphasise the impor-
tance of testing when patients come for treatment’ and ‘...
form support groups’. Less frequent propositions (8.9%)
included: ‘They should test all patients’, ‘...should not
give [TB] treatment without an HIV-test result’, ‘...should
provide mobile testing’, and ‘...provide incentives to test’.
Discussion
Almost one-third (32.5%) of TB patients participating in
our study had, by their own report, not undergone HIV
testing. These patients’ reasons for non-uptake of HIV
testing mostly amounted to patient-/individual-level fac-
tors. It had not been foreseen that many of the untested
patients would be ‘undecided’ about undergoing HIV
testing. However, drawing from previous findings
amongst pregnant women in the USA [22] and a quanti-
tative analysis related to the current TB patient popula-
tion [10] on the significant association between definite
H I V - r e l a t e dk n o w l e d g ea n du p t a k eo fH I Vt e s t i n g ,a
possible explanation for the patients’‘ indecisiveness’
could be that they were not adequately informed about
the TB-HIV link. In line with research in Cambodia
[23], most of the total group of tested and non-tested
patients in our study suggested that intensifying dissemi-
nation of TB-HIV information by health care workers
would facilitate their uptake of HIV testing.
Alternatively, given that testing for HIV positions peo-
ple as being ‘at risk’ [24], it is possible that patients who
were categorised as ‘undecided’ actually had no intention
of undergoing HIV testing - perhaps for fear of being
portrayed as ‘promiscuous’. Again, the possibility exists
that some of these patients might in fact actually already
have undergone HIV testing but did not wish to reveal
this, or indeed wished to keep their HIV status secret.
Our findings showed a substantial proportion of the
patient sample to be worried about either contracting or
already having contracted and unknowingly been
spreading HIV. This seemed to be a reasonable concern
since more than half of all patients by their own report
had not used condom protection during their most
recent sexual encounter. Hence non-tested patients’ sup-
posed ‘indecision’ could have been a way to avoid
further interrogation from the interviewers.
As with studies amongst TB populations elsewhere
[13-15], some patients in our sample had not undergone
HIV testing because of fear of HIV testing as such or
because of the anticipated consequences of testing HIV-
positive, such as being stigmatised. The reality of these
patients’ fear can be tied to diverse factors, including psy-
chological issues [25], interpersonal relationships [14],
46.1
33.3
8.9
11.7
TB-HIV IEC Motivation/support Other Do not know
%
Figure 3 Patients’ suggestions on what health care workers can do to make HIV testing acceptable to TB patients (n = 666 citations).
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among TB suspects and patients in Kenya, it was envi-
saged that the implementation of PITC for TB patients in
high HIV-prevalence settings would not only scale up HIV
testing, but would also contribute to the mitigation of
fears associated with uptake thereof [27]. Yet, as seen in
our study, patients’ fear of HIV testing persists. By implica-
tion, routine/PITC alone may be insufficient towards scal-
ing up HIV testing amongst TB patients. As suggested by
patients in our study, there is a need to implement a
supplementary broader ethos of motivation and support.
Though research has indicated that TB patients are
generally enthusiastic about collaborative TB and HIV
activities [28], some patients in our study were neverthe-
less unwilling to undergo HIV testing, explaining that
they still needed to deal with the burden of TB. These
patients might have been concerned about the possibi-
lity of negative interactions between jointly administered
TB and HIV drugs. Indeed, dual administration of TB
and HIV treatment may present challenges such as
overlapping and additive toxicities [29,30]. However,
such potential challenges should be outweighed by evi-
dence demonstrating the feasibility, effectiveness and
tolerability of dually-administered TB and HIV therapy
[31,32]. There thus seems to be a need to (better)
inform patients regarding the advantages of simulta-
neous treatment for TB and HIV.
Similar to findings of a Cambodian study [33], more
than half of non-tested patients in the present study
reported that it had not been recommended to them
that they undergo HIV testing. The lack of standardisa-
tion of clinical records meant that verification of such
reports was not possible. However, to the extent that
these patient reports are true, such a lack of provider-
initiation of HIV testing could have adverse implications
for meeting the target of 100% HIV testing by TB
patients by 2011 [4]. At the same time, given that it is
widely believed and proclaimed that HIV testing should
be recommended to all TB patients in high HIV-preva-
lence settings [2,3,34], the non-practice of provider-
initiation of HIV testing raises concerns about health
workers’ professional ethics and/or training, support and
supervision in respect of PITC for TB patients. Our
exploratory research suggests that it is imperative for
TB control programmes to focus more attention on the
implementation of the PITC policy directive.
As far as improving uptake of HIV testing is con-
cerned, most patients asserted that it could be increased
by motivation and support of TB patients by both health
care workers and significant others in their commu-
nities. Also, providing (more) TB-HIV information to
patients was perceived to be a salient role for health
care providers. Our findings align with evidence from
research in Kenya, which established that combined
facility and community efforts are feasible and do indeed
contribute to the scaling up of HIV testing [27].
Convenience sampling of patients limits the extent to
which the findings may be generalised to populations of
TB patients beyond the four sub-districts surveyed in
the present study. However, as previously mentioned,
comparison revealed that the patient sample did not dif-
fer significantly from the larger population of TB
patients in respect of key biographical variables includ-
ing sex and age.
Like all research based on self-reports, the current
findings are subject to bias. The possibility of inter-
viewer bias such as unintentional errors resulting from
interviewers omitting questions or misunderstanding
respondents is acknowledged. To reduce such bias we
exercised in-field quality control including the immedi-
ate editing of questionnaires for completeness and accu-
racy. Where necessary, patients were traced to provide
or clarify missing information. Our study does however
offer insight into TB patients’ perspectives regarding
non-uptake of HIV testing in a specific context.
An important question left unanswered by the current
research is that one of the reasons for non-uptake of
HIV testing during a current episode of TB might be
that patients had been tested for HIV at an earlier stage
but due to fear of stigmatisation or other reasons,
wished to conceal that and keep their HIV status secret.
Our research also did not fully investigate the roles of
gender and age. While it was observed that male and
older TB patients were less likely to report having been
tested for HIV, the reasons for such tendencies and how
they can be addressed need to be understood in order
to develop appropriate interventions for groups at high
risk not to test for HIV.
Conclusion
Our study found patient-/individual-related factors or
personal reasons to figure prominently in TB patients’
explanations for non-uptake of HIV testing. This finding
contributes to efforts to understand the limited success,
to date, of routine/PITC implementation in South
Africa. The only health system-related factor that fea-
tured - albeit much less prominently - in the patients’
accounts of their non-uptake of HIV testing, was the
reported non-offer of HIV testing at PHC facilities.
The study findings suggest that from the TB patients’
perspective, initiatives to scale up HIV testing by TB
patients in the Free State need to consider additional
measures to augment routine/provider-initiation of HIV
testing. The surveyed patients expressed a need for
(more) motivation by and support from both health care
workers and significant others, including family, friends
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(more) consistently and repeatedly inform and educate
patients about the link between TB and HIV.
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